Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1992;118(3):171-5.
doi: 10.1007/BF01410129.

The additive effect of alpha-difluoromethylornithine (DFMO) and radiation therapy on a rat glioma model

T Tsukahara  1 , M Tamura, H Yamazaki, H Kurihara, S Matsuzaki
Affiliations

The additive effect of alpha-difluoromethylornithine (DFMO) and radiation therapy on a rat glioma model

T Tsukahara et al. J Cancer Res Clin Oncol. 1992.

Abstract

The effects of alpha-difluoromethylornithine (DFMO), radiation and the therapy of their combination were investigated in rats bearing G-XII glioma. DFMO treatment as well as radiation therapy prolonged the survival period when compared to the results in non-treated control rats. The combination therapy showed a greater effect on the survival rate than the single therapies, the effect being additive. The concentration of putrescine, spermidine, and N1-acetylspermidine in tumor tissue was lowered by DFMO, while that of spermine was slightly elevated. Radiation decreased the concentration of all the polyamines, putrescine, spermidine, spermine and N1-acetylspermidine. The concomitant treatment with DFMO and radiation further decreased the concentrations of putrescine and N1-acetylspermidine in tumor tissues. The survival period of glioma-bearing rats is inversely correlated with the tissue levels of putrescine plus N1-acetylspermidine.

PubMed Disclaimer

References

    1. Deen DF, Tofilon PJ (1984) Combined effect of drugs and radiation against tumor cells. In: Rosenblum ML, Wilson CB (eds) Progress in experimental tumor research, vol 28. Brain tumor therapy. Karger, Basel, pp 183–197 - PubMed
    1. Eklint MM (1977) Fundamental questions in the combined use of radiation and chemicals in the treatment of cancer. J Radiat Oncol Phys 5:1711–1720 - PubMed
    1. Harik SI, Sutton CH (1979) Putrescine as a biochemical marker of malignant brain tumor. Cancer Res 39:5010–5015 - PubMed
    1. Heby O, Marton LJ, Wilson CB, Martinetz HM (1975) Polyamine metabolism in a rat brain tumor cell line: its relationship to the growth rate. J Cell Physiol 86:511–522 - PubMed
    1. Hoshino T, Nagashima T, Murovic JA, Wilson CB, Edwards MSB, Gutin PH, Davis RL, Dearmond SJ (1986) In situ cell kinetics studies on human neuroectodermal tumors with bromodeoxyuridine labeling. J Neurosurg 64:453–459 - PubMed

LinkOut - more resources